SUMMARY Human papillomavirus (HPV) infection of cervical intraepithelial neoplasia (CIN) and invasive cervical carcinoma was investigated using in situ DNA-DNA hybridisation on histological sections of formalin fixed, paraffin embedded tissue to assess the technique's sensitivity and to assess retrospectively the association between HPV16 and invasive cervical carcinoma. HPV DNA was detected in 16 of 33 biopsy specimens of CIN. Cells containing viral DNA were more numerous than those positive for viral structural proteins. HPV DNA was also present in less differentiated cells deeper in the epithelium. The detection rate in CIN was lower than that reported for other hybridisation techniques such as Southern blotting. In a retrospective study of biopsy specimens of invasive squamous carcinoma of the cervix HPVl6 DNA, the virus most commonly associated with cervical malignant disease, was found in 20 of 25 cases, including those dating from as far back as 1932. The level of sensitivity was similar to that reported for other hybridisation techniques. DNA positive cells were focally distributed in the invasive tumours, and most tumour cells were negative for viral DNA, a result consistent with the low copy number found in malignait cells.
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It is concluded that HPV16 is not a new virus but that its prevalence is a result ofchanges in sexual behaviour and that in situ hybridisation is useful in the localisation of HPV DNA replication in CIN and invasive carcinoma.
Genital human papillomaviruses (HPV) Sections were stained with a genus specific bovine papillomavirus antibody (Dako B580) at 1/300 as previously described.'3 Some sections which had been stained for viral antigens were then processed for DNA-DNA hybridisation. Triton X (0-1%) was added to the hybridisation mix to prevent non-specific binding of the probe to positively stained cells.'9
Results

PENETRATION OF DNA PROBES
To facilitate penetration of the probe into cells in tissues fixed by formalin, proteinase digestion and the use of fragmented DNA were found to be necessary. Proteinase digestion was critical and 2 mg/ml of proteinase K for five minutes at room temperature was found to be optimal.
Digestion of the DNA probe with the restriction endonuclease Pstl and nick translation with a DNAse concentration of 1 25 ng/ml produced a probe mostly of 200-400 base pairs in length (fig 1) .
SPECIFICITY AND SENSITIVITY OF DNA PROBES
The specificities of the probes were tested in three ways. In one test a condylomata containing HPV6 DNA (fig 2a) was hybridised with HPV type 16 DNA and no signals were observed (fig 2b) . Secondly, a 1000-fold excess of unlabelled HPV6 DNA was hybridised along with the "S-labelled HPV probe and no signal was detected by autoradiography. Thirdly, a biopsy section of the same HPV6 containing lesion was hybridised with "S-labelled HPV type 1 DNA. detected only HPV16 in malignant disease in our clinic population.3 Sections from carcinomas were hybridised with HPV6 DNA as a control for specificity. Although 30 specimens of invasive carcinomas taken between 1932 and 1986 were investigated, results were available from only 25 because of detachment of sections from slides during the processing of tissue from the 1950s. Twenty of the 25 (80%) were positive for HPV16 DNA (table 2). The earliest positive biopsy specimen was from a case seen in 1932  (fig 4) , the oldest specimen examined. All sections were negative for the presence of HPV6 DNA.
HPV16 positivity was focally distributed within the tumour and most of the tumour cells were negative. HPV DNA was shown more often and most strongly in maturing cells in differentiated areas of tumour. Although a strong signal for HPV DNA was detected from individual tumour cells, no HPV structural antigens were detected in any of the tumours tested.
Discussion
In CIN, HPV sequences were detected in 49% of biopsy specimens: 6 The finding of HPV 1 6 DNA in biopsy specimens of invasive cervical cancer taken over 50 years ago and the consistent presence of the virus throughout the subsequent period indicates that HPV16 is not a new virus and that the association with cancer of the cervix is a long established one. The recent increase in detected HPV infection of the lower genital tract and in associated intraepithelial neoplasia and invasive cancer cannot, therefore, be ascribed to a new type of HPV infection. A more likely explanation would be that changes in sexual habits have resulted in an increase of transmission of the virus. We have previously shown that HPV infection was found with the same prevalence in CIN lesions in a high risk group of women examined in Holloway prison in London during the early 1970s as in our current clinic population.22 Changes in behaviour may have led to a spread of this infection into the general population. 23 Although the sensitivity of in situ hybridisation is at present superior to immunohistochemisty as it is both specific and more sensitive, it is not as sensitive as Southern blotting. The requirement for radiolabelling of probes also limits its present application as a diagnostic method, but it is useful in the localisation of HPV DNA replication in CIN and invasive cancer and in the demonstration of the long history of the association between HPV16 and cervical carcinoma.
